UK Medical Eligibility for Contraceptive Use 2016

Product Information

FSRH CEU Statement to published systematic review: The relationship between progestin hormonal contraception and depression: a systematic review (March 2018) In addition there are categories for Initiation of a method by a woman with a specific condition and Continuation of a method in a woman who develops a new medical condition. What does all this mean in practice? Firstly, this update sees the removal of split categories, where more than one category is assigned to a given condition (e.g. 2/3 or 3/4 categories). 2 This is a change that, I would anticipate, will be warmly welcomed by clinicians. 1 Instead those conditions with previously split categories, such as viral hepatitis and diabetes, have been added to or expanded upon 1 to aid clinicians in making a more patient-centred judgement about the applicability of a method to a given individual.

Looking at a combined hormonal method a woman with a BMI of 30 would be a UKMEC 2 (generally use) but if she had a BMI of 35 this would be a UKMEC 3 (probably don’t use); a woman who has migraine with aura would be a UKMEC 4 (Do Not Use); The UK Medical Eligibility Criteria (UK MEC 2016) is the authoritative, ‘go-to’ reference for clinicians providing contraceptives safely across the life course. FSRH CEU Statement: Response to new study by Meaidi et al (2023) Venous thromboembolism with use of hormonal contraception and non-steroidal anti-inflammatory drugs (September 2023) The UKMEC is a set of guidance criteria that enable and support clinicians to deliver safe, evidence-based contraceptive care to women.The initiation (I) and continuation (C) of a method of contraception can sometimes be distinguished and classified differently (see tables in this Guidelines summary). The duration of use of a method of contraception prior to the new onset of a medical condition may influence decisions regarding continued use. However, there is no set duration and clinical judgement will be required.

This Guidelines summary covers the key conditions that women commonly present with in a primary care setting. Please refer to the full guideline for evidence, clarifications, and additional comments associated with the recommendations. Aims of the UKMEC Guideline Contraception is free on the NHS. Find out where to get contraception and search by postcode to find: Please read this guidance document in conjunction with any relevant clinical statements for this topic:In line with the release of the 2016 UKMEC, we are launching this key guidance for nurses, which we hope will help them to make the most of the new tool, enabling them to identify which methods can safely be used by which women and when. These evidence-based recommendations do not indicate a best method for a woman nor do they take into account efficacy—and this includes drug interactions or malabsorption A condition where the theoretical or proven risks usually outweigh the advantages of using the method. The provision of a method requires expert clinical judgement and/or referral to a specialist contraceptive provider, since use of the method is not usually recommended unless other more appropriate methods are not available or not acceptable